Peripheral blood lymphocytes from coronary artery disease (CAD) patients show overexpression of TXNIP induced by the loss of DNA methylation levels in its 3′UTR regulatory region, promoting inflammasome activation [108]. Here, TXNIP is linked to coronary artery disorder.